Preliminary Study of Effects of Multiple Oral Dosing of Clarithromycin on the Pharmacokinetics of Cyclosporine in Dogs

• Published in: Journal of Veterinary Medical Science Vol. 76; no. 3; pp. 431 - 433
• Main Authors: KATAYAMA, Masaaki, KAWAKAMI, Yoshiki, KATAYAMA, Rieko, SHIMAMURA, Shunsuke, OKAMURA, Yasuhiko, UZUKA, Yuji
• Format: Journal Article
• Language: English
• Published: Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 2014; Japan Science and Technology Agency; The Japanese Society of Veterinary Science
• Subjects: Administration, Oral; Animals; Biological Availability; clarithromycin; Clarithromycin - administration & dosage; Clarithromycin - pharmacology; cyclosporine; Cyclosporine - metabolism; Cyclosporine - pharmacokinetics; Dogs; Dose-Response Relationship, Drug; Immunosuppression - methods; Immunosuppression - veterinary; pharmacokinetics; Pharmacology; renal transplantation
• ISSN: 0916-7250; 1347-7439
• DOI: 10.1292/jvms.13-0209

Clarithromycin (CLM) has been known to increase the cyclosporine (CsA) trough level in human and feline organ transplant patients. However, the interaction of CLM with CsA has not been reported in dogs. In this study, the effects of multiple dosing of CLM on the pharmacokinetics of CsA in three healthy beagles were investigated. The treatments included CsA 10 mg/kg alone and CsA 10 mg/kg + multiple-dose of CLM 10 mg/kg. Co-administration of CLM with CsA resulted in significant increases of oral bioavailability of CsA. The results of our study suggest that administration of multiple therapeutic doses of CLM may decrease the required CsA dosage in CsA-based immunosuppressive therapy in renal transplanted dogs.